RRM1

Ribonucleoside-diphosphate reductase large subunit · P23921 · RRM1 on Sugi Atlas →

12,293 patent compounds predicted against RRM1, 8,579 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL1638485 SCHEMBL1638485 0.63 7/20
SCHEMBL1639477 SCHEMBL1639477 0.77 6/20
SCHEMBL1639479 SCHEMBL1639479 0.77 6/20
SCHEMBL1637574 SCHEMBL1637574 1.00 5/20
SCHEMBL1637575 SCHEMBL1637575 1.00 5/20
SCHEMBL1173951 SCHEMBL1173951 0.65 5/20
SCHEMBL1173953 SCHEMBL1173953 0.65 5/20
SCHEMBL1639361 SCHEMBL1639361 0.56 5/20
SCHEMBL1639362 SCHEMBL1639362 0.56 5/20
SCHEMBL1638800 SCHEMBL1638800 0.56 5/20
SCHEMBL1639071 SCHEMBL1639071 0.56 5/20
SCHEMBL800974 SCHEMBL800974 0.77 4/20
SCHEMBL1679411 SCHEMBL1679411 0.77 4/20
SCHEMBL683715 SCHEMBL683715 0.76 4/20
SCHEMBL2847708 SCHEMBL2847708 0.76 4/20
SCHEMBL1639305 SCHEMBL1639305 0.72 4/20
SCHEMBL1639307 SCHEMBL1639307 0.72 4/20
SCHEMBL2439831 SCHEMBL2439831 0.53 4/20
SCHEMBL2439834 SCHEMBL2439834 0.53 4/20
Orthocresol Orthocresol (SCHEMBL2131451) 0.48 4/20

Clinical trials — most relevant to RRM1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer PHASE2COMPLETED
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema PHASE2COMPLETED
Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC PHASE2COMPLETED
Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa PHASE1COMPLETED
DNA Repair Genes and Outcomes in Patients With Stage III NSCLC nanUNKNOWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer nanUNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Predictive Study of Radiation Induced Sarcoma nanCOMPLETED
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
Molecular Genetics of Retinal Degenerations nanCOMPLETED
Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions nanCOMPLETED
Studying Genes in Samples From Younger Patients With Rhabdomyosarcoma nanCOMPLETED
Improving Genetic Counseling for Patients With Spina Bifida Using Next Generation Sequencing nanCOMPLETED
A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients nanCOMPLETED
Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo Models nanCOMPLETED
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Clinical Study of Spinal Muscular Atrophy nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy nanCOMPLETED
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Genetic Factors Affecting the Severity of Beta Thalassemia nanCOMPLETED
Study of Specimens From Young Patients With Neuroblastoma nanCOMPLETED
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants nanRECRUITING
Role of Genetic Factors in the Development of Lung Disease nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a RRM1 binder may also engage these)

ProteinNameSimilarity
P36602 1.000 P36602 →
Q5R919 1.000 Q5R919 →
Q03604 1.000 Q03604 →
P79732 1.000 P79732 →
P07742 0.999 P07742 →
P48591 0.999 P48591 →
P20503 0.998 P20503 →
Q9SJ20 0.996 Q9SJ20 →
P21524 0.996 P21524 →
P50648 0.996 P50648 →
P50647 0.995 P50647 →
Q54Q71 0.995 Q54Q71 →
P12848 0.995 P12848 →
P0DSV2 0.994 P0DSV2 →
A0A7H0DN52 0.993 A0A7H0DN52 →
P0DSV1 0.992 P0DSV1 →
O61065 0.992 O61065 →
Q76RD8 0.991 Q76RD8 →
P55982 0.990 P55982 →
P32282 0.990 P32282 →
Q9UW15 0.990 Q9UW15 →
P43754 0.989 P43754 →
Q89AS4 0.988 Q89AS4 →
P21672 0.988 P21672 →
P37426 0.988 P37426 →
P00452 0.987 P00452 →
O15909 0.987 O15909 →
Q9ZLF9 0.986 Q9ZLF9 →
P28903 0.986 P28903 →
Q8K9W3 0.984 Q8K9W3 →